The Jewish General Hospital, known officially as the Sir Mortimer B. Davis Jewish General Hospital since 1978, is an acute-care teaching hospital in Montreal, Quebec, Canada. The hospital is affiliated with McGill University and has 637 beds, one of the most of a hospital site in Canada.

There are 637 beds in Cardiovascular Prevention Centre, Jewish General Hospital.

During the past decade, Cardiovascular Prevention Centre, Jewish General Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiovascular Prevention Centre, Jewish General Hospital" #1 collaborator was "Merck Frosst Canada Ltd." with 1 trials as a collaborator and "Novartis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Cardiovascular Prevention Centre, Jewish General Hospital" are "Diabetes" (1 trials), "Hypertension" (1 trials), "Pre-diabetes" (1 trials) and "Pre-hypertension" (1 trials). Many other conditions were trialed in "Cardiovascular Prevention Centre, Jewish General Hospital" in a lesser frequency.

Most popular intervention types in "Cardiovascular Prevention Centre, Jewish General Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Aliskiren vs. hydrochlorothiazide" (1 trials), "Hydrochlorothiazide" (1 trials) and "losartan, hydrochlorothiazide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiovascular Prevention Centre, Jewish General Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Cardiovascular Prevention Centre, Jewish General Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Cardiovascular Prevention Centre, Jewish General Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiovascular Prevention Centre, Jewish General Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".